Symptomatic Irreversible Pulpitis Managed with Dexamethasone during Delayed Endodontic Treatment: A Case Series
Abstract
Managing pain of endodontic origin is most often achieved via pulpotomy, pulpectomy, or nonsurgical root canal therapy in conjunction with postoperative analgesics. In the event endodontic treatment cannot be initiated promptly, an effective pain management protocol targeting reduction of inflammatory mediators is invaluable. Dexamethasone may provide an optimal approach to managing symptomatic irreversible pulpitis when endodontic treatment cannot readily be provided. Reasons for delayed treatment include but is not limited to: scheduling conflicts, lack of staffing support, inability to achieve profound anesthesia, difficult anatomy, or canal obstructions impeding adequate debridement. This article will review inflammatory pathways, as well as dexamethasones mechanism of action to help facilitate discussion on its use for managing endodontic pain. A case series documenting dexamethasones ability to adequately manage pain associated with symptomatic irreversible pulpitis during delay of endodontic treatment by one week demonstrates potential for this regimen.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jun 30, 2023
- Accession Number
- AD1222331
Entities
People
- Jonathan J. Dismuke
- Joseph M. Dutner
- Kurt B. Goodell
- Matthew B. Phillips
Organizations
- Uniformed Services University of the Health Sciences